Simplex Trading
SGMT icon

Simplex Trading’s Sagimet Biosciences SGMT Stock Holding History

Simplex Trading’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
41,300
+11,300
+38% +$63K ﹤0.01% 4218
2025
Q4 		$178K Sell
30,000
-21,500
-42% -$154K ﹤0.01% 4348
2025
Q3 		$353K Sell
51,500
-12,800
-20% -$104K ﹤0.01% 4264
2025
Q2 		$489K Buy
64,300
+26,700
+71% +$113K ﹤0.01% 3529
2025
Q1 		$122K Buy
37,600
+31,500
+516% +$132K ﹤0.01% 4861
2024
Q4 		$27K Buy
+6,100
New +$30.9K ﹤0.01% 6457

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Simplex Trading's SGMT Position: Q1 2026 in Review

Simplex Trading reduced its Sagimet Biosciences (SGMT) stake by 4.2% in Q1 2026, selling an estimated $3.29K and leaving 13,636 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5474.

Simplex Trading first reported a position in SGMT in Q2 2024 and has held it in 6 quarters since. The position peaked at $84.2K in Q4 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Simplex Trading held 13,636 shares of Sagimet Biosciences worth $71.2K as of Q1 2026.
  • Simplex Trading sold 591 Sagimet Biosciences shares in Q1 2026, an estimated $3.29K.
  • Sagimet Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5474 holding.
  • Simplex Trading first reported a position in Sagimet Biosciences in Q2 2024 and has held it in 6 quarters since.
  • Simplex Trading's Sagimet Biosciences position peaked at $84.2K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.